Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Cardiac risk factors and prevention

Original research article

Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease

Online download statistics by month:

Online download statistics by month: April 2018 to February 2023

	Abstract	Full	Pdf
Apr 2018	1460	195	81
May 2018	559	55	31
Jun 2018	254	15	11
Jul 2018	205	10	7
Aug 2018	228	8	8
Sep 2018	565	47	45
Oct 2018	565	71	45
Nov 2018	175	18	10
Dec 2018	150	5	6
Jan 2019	104	16	8
Feb 2019	120	9	10
Mar 2019	163	18	11
Apr 2019	108	15	4
May 2019	106	9	4
Jun 2019	81	8	6
Jul 2019	73	10	8
Aug 2019	75	2	2
Sep 2019	76	5	3
Oct 2019	121	3	1
Nov 2019	36	7	3
Dec 2019	67	4	4
Jan 2020	63	5	1
Feb 2020	76	3	2
Mar 2020	49	7	2
Apr 2020	59	3	2
May 2020	38	1	1
Jun 2020	69	6	0
Jul 2020	30	3	0
Aug 2020	43	3	2
Sep 2020	68	7	3
Oct 2020	45	0	0
Nov 2020	62	2	2
Dec 2020	40	2	2
Jan 2021	22	8	3
Feb 2021	29	4	2
Mar 2021	52	9	5
Apr 2021	21	0	0
May 2021	7	1	2
Jun 2021	10	9	2
Jul 2021	7	7	1
Aug 2021	5	1	1
Sep 2021	3	3	0
Oct 2021	54	6	2
Nov 2021	53	2	2
Dec 2021	50	6	4
Jan 2022	25	4	0
Feb 2022	19	7	5
Mar 2022	50	4	1
Apr 2022	31	1	0
May 2022	46	5	0
Jun 2022	31	5	1
Jul 2022	38	0	0
Aug 2022	77	5	3
Sep 2022	60	12	0
Oct 2022	46	6	1
Nov 2022	52	3	0
Dec 2022	26	2	2
Jan 2023	39	2	0
Feb 2023	70	0	0
Total	6856	684	362